Douglas E. Feltner

Insider

First SEC filing: June 5, 2020 · Latest: June 5, 2020

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Nov. 15, 2021	XCUR	A	7,500	$0.91	$6,825	15,000 Direct	+100.00%	Acquired	-99.0% (price as of 2026-08-19)
May 14, 2021	XCUR	A	7,500	$1.27	$9,525	7,500 Direct	—	Acquired	-99.2% (price as of 2026-08-19)
April 27, 2021	XCUR	A	220,000	—	—	220,000 Direct	—	Acquired	(price as of 2026-08-19)
June 3, 2020	XCUR	A	400,000	—	—	400,000 Direct	—	Acquired	(price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
April 27, 2021	XCUR	Employee Stock Option (right to buy)	Common Stock (220,000)	$1.90	April 26, 2031	220,000	Acquired
June 3, 2020	XCUR	Employee Stock Option (right to buy)	Common Stock (400,000)	$2.72	June 2, 2030	400,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Matched by name from proxy statements (DEF 14A) — verify against the filing.

M.D.(11) Former Chief Medical Officer

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2020	$239,882	—	—	$770,480	$63,480	—	—	$1,073,842

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.